Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obsessive-compulsive disorder in elderly patients

C W Jackson1

  • 1Institute of Psychiatry, Medical University of South Carolina, Charleston, USA.

Drugs & Aging
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extremely Low Frequency Electromagnetic Fields impair the Cognitive and Motor Abilities of Honey Bees.

Scientific reports·2018
Same author

Evolutionary aspects of ant-fungus interactions in leaf-cutting ants.

Trends in ecology & evolution·2011
Same author

The Src requirement for washed platelet aggregation and dense granule secretion in response to stimulation by a low level gamma-thrombin.

Journal of thrombosis and haemostasis : JTH·2008
Same author

FcRgamma-chain-dependent alphaIIbeta3 elicited outside-in signaling.

Journal of thrombosis and haemostasis : JTH·2006
Same author

FcRgamma-chain signals in the absence of glycoprotein VI.

Journal of thrombosis and haemostasis : JTH·2006
Same author

The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.

Journal of thrombosis and haemostasis : JTH·2004
Same journal

Correction: Guideline-Directed Heart Failure Pharmacotherapy in Adults Aged ≥75 Years: Evidence Gaps, Tolerability, and Implications for Clinical Practice.

Drugs & aging·2026
Same journal

Targeted Treatment for Hyperuricemia: The Drug Pipeline.

Drugs & aging·2026
Same journal

Efficacy and Safety of Ciprofol Versus Propofol for Anesthesia in Older Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Drugs & aging·2026
Same journal

Leveraging Real-World Data for Clinical Decision Making in Geriatric Oncology.

Drugs & aging·2026
Same journal

Drug Utilisation of Fall-Risk-Increasing Drugs (FRIDs) and Risk of Hospitalisation: A Nested Case-Control Study Among Community-Dwelling Older Adults.

Drugs & aging·2026
Same journal

Gabapentinoid Use and Risk of Alzheimer's Disease-Related Dementias: A Systematic Review and Meta-analysis of Observational Studies.

Drugs & aging·2026
See all related articles

Obsessive-compulsive disorder (OCD) affects adults and is linked to serotonin and dopamine system issues. Treatment involves medications like clomipramine and serotonin reuptuptake inhibitors, alongside behavioral therapy.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Obsessive-compulsive disorder (OCD) is a prevalent mental health condition.
  • It typically emerges in young adulthood and can persist throughout life.
  • OCD involves dysregulation in serotonin and potentially dopamine systems.

Purpose of the Study:

  • To review the understanding and management of obsessive-compulsive disorder (OCD).
  • To highlight considerations for late-onset OCD in elderly patients.
  • To discuss pharmacological and behavioral treatment strategies for OCD.

Main Methods:

  • Literature review of OCD pathophysiology and treatment.
  • Analysis of pharmacokinetics and pharmacodynamics of OCD medications.
  • Integration of evidence for combined pharmacological and behavioral interventions.

Related Experiment Videos

Main Results:

  • Serotonin system dysregulation is central to OCD, with dopamine involvement also noted.
  • Late-onset OCD warrants consideration of organic or neurological causes.
  • Clomipramine and serotonin reuptake inhibitors are primary pharmacotherapies.
  • Age-related pharmacokinetic changes necessitate careful drug selection and dosing in elderly patients.

Conclusions:

  • Effective OCD management requires a combination of pharmacotherapy and behavioral therapy.
  • Treatment choices should balance efficacy, adverse effect profiles, and patient-specific factors, including age.
  • Understanding neurochemical underpinnings guides therapeutic strategies for OCD.